Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Arch Dermatol Res ; 308(9): 643-654, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27623800

ABSTRACT

Skin aging is a natural process of the human body that may be accelerated due to extrinsic causes. Libidibia ferrea, popularly known as jucá, is a small tree, which possesses an abundant phenolic composition with potential antioxidant and enzymatic inhibition activities. Thus, this work aimed to investigate the anti-wrinkle and anti-whitening potentials of jucá trunk bark (LFB) and pod (LFP) extracts. A comprehensive analysis of LFB and LFP phenolic composition was accomplished by means of liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Effects on skin degradation were assessed by inhibitory enzymatic activity against elastase, hyaluronidase and collagenase through colorimetric assays. Cellular viability in B16F10 and primary fibroblasts were determined by Trypan Blue exclusion assay. Anti-melanogenic effects on B16F10 cells were evaluated using cellular tyrosinase, melanin content, western blot, and RT-qPCR analyses. Inhibition of matrix metalloproteinase-2 and metalloproteinase-9 (MMP-2 and MMP-9) was determined by gelatin zymography and western blot methodologies. LC-MS/MS analyses of LFB and LFP extracts allowed the characterization of 18 compounds, among them, flavonoids, phenolic acids, and secoridoids. Additionally the pod and trunk bark compositions were compared. Hyaluronidase inhibitory activity for both extracts, LFB (IC50 = 8.5 ± 0.8 µg/mL) and LFP (IC50 = 16 ± 0.5 µg/mL), was stronger than standard rutin (IC50 = 27.6 ± 0.06). Pro-MMP-2 was significantly inhibited by both extracts. LFB and LFP decreased the melanin content in B16F10 due to tyrosinase inhibitory activity. L. ferrea extracts has high potential as a cosmetic ingredient due to its anti-wrinkle and depigmentant effects.


Subject(s)
Caesalpinia/chemistry , Melanins/metabolism , Plant Extracts/pharmacology , Skin Aging/drug effects , Animals , Antioxidants/pharmacology , Cell Line, Tumor , Cell Survival , Cosmetics/pharmacology , Enzyme Precursors/metabolism , Fibroblasts , Flavonoids/pharmacology , Gelatinases/metabolism , Humans , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Mice , Monophenol Monooxygenase/metabolism , Phenols/pharmacology , Plant Bark , Primary Cell Culture , Tandem Mass Spectrometry
2.
São Paulo; s.n; s.n; abr. 2015. 125 p. tab, graf, ilus.
Thesis in Portuguese | LILACS | ID: biblio-836664

ABSTRACT

A exposição excessiva à radiação Ultravioleta (UV) resulta em manifestações clínicas à pele humana como queimaduras, fotoenvelhecimento e câncer. A radiação UVA, preferencialmente, induz à formação de espécies reativas de oxigênio, enquanto que a radiação UVB é absorvida diretamente pelo DNA. Apesar de mecanismos endógenos auxiliarem na prevenção/reparação dos danos causados pela radiação UV, quando o dano excede a capacidade de reparação celular, diversos efeitos lesivos ocorrem na pele como alterações da matriz dérmica, resposta inflamatória e desidratação do estrato córneo. O uso de compostos fenólicos com atividade antioxidante pode auxiliar na prevenção das consequências patológicas da exposição à radiação UV. O presente trabalho teve como objetivo estudar em cultura de células da pele (HaCaT -queratinócito humano imortalizado e FHPD - fibroblasto humano primário dermal) exposta às radiações UVA e UVB a atividade fotoprotetora de 3 compostos fenólicos, ácido cafeico (AC), clorogênico (ACG) e rosmarínico (AR). Inicialmente, células HaCaT e FHPD cultivadas em monocamada foram expostas às doses crescentes de radiação UVA ou UVB e, após 24 horas, foram analisadas quanto a viabilidade, marcadores de morte celular, mediadores inflamatórios, presença de aquaporina e lesões de DNA. HaCaT quando exposta às radiações UVA e UVB são conduzidas à morte por apoptose, com aumento de Caspases 3 e 9, p53 e redução de PARP. Após a exposição à radiação UVA, HaCaT responde com aumento na liberação de IL-6, TNF-α e COX-2, internalização/redução de AQP3 da membrana, redução na liberação de MMP-2 e 9, aumento na liberação de MMP-1 e na produção de ERO. Quando expostos à radiação UVB, HaCaT aumenta a liberação de IL-6 e COX-2, promove internalização/redução de AQP3 na membrana e redução na liberação de MMP-2 e 9. FHPD são menos sensíveis à exposição a ambas as radiações, mostrando redução de viabilidade com parada de ciclo apenas frente à radiação UVA. Além disto, FHPD exposto a radiação UVA responde com aumento na liberação de IL-6 e danos no DNA do tipo 8-oxo-dG. Dentre os compostos, o ACG apresentou melhor atividade fotoquimioprotetora perante ambas as radiações UVA e UVB, pois foi capaz de reverter em HaCaT a morte celular induzida por ambas as radiações e de reverter a parada de ciclo em FHPD expostos à radiação UVA. HaCaT tratado com ACG e exposto à radiação UVA responde com aumento na expressão de AQP3 e PARP, aumento na expressão gênica de AQP3, redução na expressão gênica de CDKN1A e na liberação de MMP-1, 2 e 9. Após a radiação UVB, o tratamento com ACG aumenta a expressão gênica de AQP3, reduz a expressão gênica de CDKN1A, reduz a produção de COX-2 e aumenta a liberação de MMP-2 e 9. O tratamento com o AR apresentou atividade fotoquimioprotetora frente à radiação UVA, com HaCaT respondendo a radiação com aumento na população de células viáveis, aumento na expressão de AQP3 e PARP e na expressão gênica de AQP3, redução na liberação de MMP-1 e 9 e redução na produção de COX-2. FHPD tratados com AR apresentaram aumento na população em fase G1, na expressão de p21, e redução de danos de DNA tipo 8-oxo-dG. O tratamento de HaCaT com AC foi capaz de reverter a morte celular, aumentar a expressão de p53 e aumentar a liberação de MMP-2 e 9 frente à radiação UVB e de reduzir a produção de ERO, a expressão de p21 e a liberação de MMP-1, 2 e 9 frente à radiação UVA. Para FHPD, o tratamento com AC foi capaz apenas de reduzir a formação de danos de DNA tipo 8-oxo-dG. Os resultados indicam que o modelo proposto foi capaz de discriminar a atividade fotoprotetora dos compostos frente à radiação UVA e UVB. Além disto, foi possível demonstrar que os compostos antioxidantes se comportam de maneira distinta enquanto fotoprotetores no modelo empregado


Excessive exposure to Ultraviolet radiation (UV) results in clinical manifestations in human skin such as burns, photo-aging and cancer. UVA radiation preferentially induces formation of reactive oxygen species, while UVB radiation is absorbed directly by the DNA. Although endogenous mechanisms are able to prevent/repair cellular damages caused by UV radiation, excess cellular damage retains cells repair capacity and also results on diverse harmful effects on skin, such as, changes in the dermal matrix, inflammatory response and dehydration of the stratum corneum. The use of phenolic compounds with antioxidant activity may help preventing pathological conditions caused by UV radiation. This work aimed to study the photoprotective activity of three phenolic compounds, caffeic (CA), chlorogenic (CGA) and rosmarinic acid (RA) in human skin cells (HaCaT - immortalized human keratinocytes and HDSF - human dermal skin fibroblast) exposed to UVA and UVB radiation. Initially, HDSF and HaCaT cells were exposed to increasing doses of UVA and UVB radiation. After 24 hours of exposure, we evaluated cell viability, cell death, inflammatory mediators, aquaporin and DNA damage. Exposure to UVA and UVB radiation in HaCaT cells results on apoptotic cell death, with an increase of caspases 3 and 9, p53 and reduction of PARP. HaCaT cells when exposed to UVA radiation resulted on increased levels of IL-6, TNF-α and COX-2, internalization of the membrane AQP3, reduction of MMP-2 and MMP-9 release, increase of MMP-1 and ROS production. After UVB radiation, HaCaT cells resulted on an increase of IL-6 and COX-2 production, it also promoted internalization of membrane AQP3 and reduced release of MMP-2 and 9. HDSF were less sensitive to both radiations. Moreover, HDSF resulted in cell viability decrease and cell cycle arrest only after UVA radiation. Furthermore, HDSF when exposed to UVA radiation resulted on an increase of IL-6 production and in DNA damage (8-oxo-dG). Among the studied compounds, CGA presented better photochemiprotective activity towards UVA and UVB radiation. Also, this compound was able to reverse cell death in HaCaT after exposure to both radiations and inhibited cell cycle arrest in HDSF after UVA radiation exposure. HaCaT cells treated with CGA and exposed to UVA radiation resulted on an increase in AQP3 and PARP expression, increased in AQP3 gene expression, reduction in CDKN1A gene expression and reduction in MMP-1, 2 and 9 release. After UVB radiation, GCA treatment increases AQP3 gene expression, reduces CDKN1A gene expression, reduces COX-2 production and increase MMP-2 and 9 releases. The AR treatment showed photochemiprotective activity towards the effects of UVA radiation, with HaCaT responding with an increase on cells viability, increased in PARP and AQP3 expression and in AQP3 gene expression, decreased MMP-1 and 9 releases and reduced COX-2c production. HDSF when treated with AR showed an increase in G1 phase population, in p21 expression and reduced DNA damage-type 8-oxo-dG. HaCaT cells treated with AC reversed cell death, increased p53 expression and increased MMP-2 and 9 releases after UVB radiation and reduced ROS production, p21 expression and MMP -1, 2, 9 release after UVA radiation. HDSF treated with AC was only able to reduce the formation of 8-oxodG DNA damage. These results indicated that the proposed model was able to discriminate the photochemiprotective activity of the studied compounds against the UVA and UVB radiation. In addition, it was demonstrated that the each studied antioxidant have different photoprotective mode of action


Subject(s)
Sunscreening Agents , Ultraviolet Rays/classification , Solar Radiation , Sun Protection Factor , Skin Aging , Phenolic Compounds/analysis , Polyphenols/pharmacology , Antioxidants/pharmacology
3.
PLoS One ; 10(3): e0118702, 2015.
Article in English | MEDLINE | ID: mdl-25742310

ABSTRACT

Malignant melanoma is a highly aggressive form of skin cancer with a high mortality rate if not discovered in early stages. Although a limited number of treatment options for melanoma currently exist, patients with a more aggressive form of this cancer frequently decline treatment. DM-1 is a sodium phenolate and curcumin analog with proven anticancer, anti-proliferative and anti-metastatic properties. In this paper, the DM-1 compound showed in vivo antitumor activity alone or in combination with chemotherapeutic DTIC in B16F10 melanoma-bearing mice. Beneficial effects such as melanoma tumor burden reduction with pyknotic nuclei, decreased nuclei/cytoplasmic ratio and nuclear degradation occurred after DM-1 treatment. No toxicological changes were observed in the liver, kidneys, spleen and lungs after DM-1 monotherapy or DTIC combined therapy. DTIC+DM-1 treatment induced the recovery of anemia arising from melanoma and immunomodulation. Both DM-1 treatment alone and in combination with DTIC induced apoptosis with the cleavage of caspase-3, -8 and -9. Furthermore, melanoma tumors treated with DM-1 showed a preferential apoptotic intrinsic pathway by decreasing Bcl-2/Bax ratio. Considering the chemoresistance exhibited by melanoma towards conventional chemotherapy drugs, DM-1 compound in monotherapy or in combination therapy provides a promising improvement in melanoma treatment with a reduction of side effects.


Subject(s)
Antineoplastic Agents, Alkylating/therapeutic use , Curcumin/analogs & derivatives , Dacarbazine/therapeutic use , Melanoma/drug therapy , Skin Neoplasms/drug therapy , Animals , Antineoplastic Agents, Alkylating/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Dacarbazine/pharmacology , Disease Progression , Drug Therapy, Combination , Male , Melanoma/pathology , Mice , Skin Neoplasms/pathology
4.
BMC Complement Altern Med ; 12: 62, 2012 May 04.
Article in English | MEDLINE | ID: mdl-22559191

ABSTRACT

BACKGROUND: Inflammatory bowel disease (IBD) is a chronic inflammation of the intestinal epithelium that is driven by the intestinal immune system, oxidative stress and the loss of tolerance to the luminal microbiota. The use of dietary products containing ingredients such as fibres and carbohydrates and/or antioxidant compounds have been used as a therapeutic strategy for intestinal diseases because these products are considered effective in the modulation of the immune system and colonic microbiota. We investigated the beneficial effects of cattail rhizome flour (Typha angustifolia L.) in the trinitrobenzenesulphonic acid (TNBS) model of rat colitis. In addition, we investigated the effects of cattail rhizome flour on the intestinal anti-inflammatory activity of prednisolone, which is a reference drug that is used for treatment of human IBD. METHODS: The present study included the preparation of flour from rhizomes of cattail (Typha angustifolia L.); an evaluation of the qualitative phytochemical profile of cattail rhizomes; an evaluation of the efficacy of cattail rhizome flour in TNBS-induced rat colitis; an evaluation of the synergistic effects of cattail rhizome flour on the intestinal anti-inflammatory activity of prednisolone; and macroscopic, clinical, biochemical, histopathological and microbiological studies to assess the healing effects of cattail rhizome flour and its synergistic effects in TNBS-induced rat colitis. The data were analysed by ANOVA, Kruskal-Wallis and χ(2) tests. RESULTS: We tested several concentrations of cattail rhizome flour and found that dietary supplementation with 10% cattail rhizome flour showed the best effects at reducing the extension of the lesion, the colon weight ratio, adherences to adjacent organs and diarrhoea. These effects were related to inhibition of myeloperoxidase (MPO) and alkaline phosphatase (AP) activities and an attenuation of glutathione (GSH) depletion. The 10% cattail rhizome flour was as effective as prednisolone, and no synergistic effects were observed. Saponins, flavonoids and coumarins were detected in the rhizome flour. No changes were observed in the total number of lactic bacteria after dietary supplementation with cattail rhizome flour. CONCLUSIONS: Dietary supplementation with 10% cattail rhizome flour and its combination with prednisolone prevent TNBS-induced colonic damage in rats, but no synergistic effects were observed. The prevention of TNBS-induced colon damage was associated with an improvement in intestinal oxidative stress, which likely resulted from the antioxidant properties of the active compounds detected in the cattail rhizome. This protective effect was not related to an improvement in lactic bacteria counts.


Subject(s)
Colitis/diet therapy , Colon/drug effects , Dietary Supplements , Inflammation/prevention & control , Phytotherapy , Plant Preparations/therapeutic use , Typhaceae/chemistry , Alkaline Phosphatase/antagonists & inhibitors , Animals , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antioxidants/metabolism , Antioxidants/pharmacology , Antioxidants/therapeutic use , Colitis/metabolism , Colitis/pathology , Colon/metabolism , Colon/pathology , Diarrhea/drug therapy , Diarrhea/etiology , Dietary Fiber/pharmacology , Dietary Fiber/therapeutic use , Disease Models, Animal , Flour , Glutathione/metabolism , Inflammation/metabolism , Inflammation/pathology , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Male , Organ Size , Peroxidase/antagonists & inhibitors , Plant Preparations/pharmacology , Prednisolone/pharmacology , Prednisolone/therapeutic use , Rats , Rats, Wistar , Rhizome , Trinitrobenzenesulfonic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...